The prevalence of women who had a positive screen for PPD at 6 weeks postpartum was 16% in our study. This rate is in agreement with many prevalence studies [7] and confirms that one in six new ...

Editor’s Note: This article was revised in May 2024 to reflect newly available peripartum mental health data and the 2023 ACOG clinical practice guideline pertaining to screening for mental health ...

Zuranolone is a novel, rapidly acting, oral medication for the treatment of postpartum depression. Zuranolone is generally ...

A certain amount of sadness and overwhelm is completely natural after giving birth. Here’s how to recognize if what you’re feeling is actually postpartum depression, and the things that can make it ...

Guilt is one of many emotions possible in postpartum depression (PPD). Seeking professional support, learning to challenge guilty thoughts, and connecting with others who share your experience can ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Budapest, Hungary — A single dose of intravenous esketamine during delivery or caesarean section appears to reduce the risk for postpartum depression (PPD) by more than 50% in the first 6 weeks, a new ...

A research team from the Department of Psychiatry at Tohoku University, led by Dr. Zhiqian Yu and Professor Hiroaki Tomita, ...

Despite being a part of many mothers' post-childbirth struggles, this subject is hardly discussed in public. But a number of ...

Last Friday the Food and Drug Administration approved the first oral pill specifically targeted to treat postpartum depression—the most common complication of childbirth. The new medication, known as ...